Search results
Keeping cancer in its place: overcoming metastasis
Nature· 2 days agoMost progress in cancer outcomes over recent decades has been driven by earlier detection and diagnosis, combined with therapies that slow the growth of...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 2 days agoSource: Global Cancer Observatory. Analysts forecast Novartis' second-quarter earnings per share to be between $1.78 and $1.84, remaining almost...
7 Benefits of Metformin (Including Weight Loss)
MediaFeed via AOL· 6 hours agoMetformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for diabetes, you probably already...
Here's Why You Should Hold Lantheus (LNTH) in Your Portfolio Now
Zacks via Yahoo Finance· 3 days agoIn March, the FDA approved label expansion for DEFINITY (Perflutren Lipid...ultrasound-enhancing...
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies - Cell...
Nature· 2 days agoForkhead box protein M1 (FOXM1) is often overexpressed in human cancers and strongly associated with therapy resistance and less good patient survival. The chemotherapy options ...
Resource-Appropriate Cancer Care, Including Coexisting Health Issues of HIV and Cancer, to be...
Newswise· 3 days agoInternational collaboration to improve cancer outcomes in Sub-Saharan Africa is working to update...
Xyosted: Mild to serious side effects and how to manage them
Medical News Today· 2 days agoXyosted (testosterone enanthate) is a brand-name injectable drug that’s prescribed for testosterone...
UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion
Reuters via Yahoo Finance· 2 days agoNovartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, ...
New technique improves T cell-based immunotherapies for solid tumors
Medical Xpress· 2 days agoScientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors—such as in melanoma, breast, and prostate & ...
The future of oncology therapies: Stingray Therapeutics’ immune-boosting breakthrough
Digital Journal· 3 days agoCurrent immune oncology treatments face a critical limitation: they are only effective in about half...
